📄 Direct examination of Dr. Robin Cotton — Wednesday, May 10, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\10\DIRECT-EXAMINATION-OF-DR-ROBIN.DOC
TRIAL
▲ Day 71 of 167

Direct examination of Dr. Robin Cotton

Witness: Dr. Robin Cotton
Examiner: George Clarke
Called by: Prosecution • Date: Wednesday, May 10, 1995 • Utterances: 185
Dr. Robin Cotton, Cellmark Diagnostics' lab director, testified about DNA typing of item 78 (bottom of Ron Goldman's shoe), walking Judge Ito through RFLP and PCR results showing a mixture of two contributors. The core finding: Nicole Brown and Ron Goldman are included as contributors; OJ Simpson is excluded. The proceeding was a hearing focused on whether the court should require statistical frequency analysis for the mixture, particularly for Goldman's four-band partial pattern.
1 MR. CLARKE:

Yes. Thank you, your Honor.

DIRECT EXAMINATION BY MR. CLARKE

2 MR. CLARKE:

Dr. Cotton, are you familiar with the issue that the Court has framed and wishes you to address?

3 DR. COTTON:

Yes, I am.

4 MR. CLARKE:

All right. With respect to in particular item no. 78, the bottom of Mr. Goldman's shoe, did you perform RFLP typing on that particular sample that was provided to your laboratory?

5 DR. COTTON:

Yes, we did.

6 MR. CLARKE:

In the course of that RFLP typing what results did you obtain?

7 DR. COTTON:

We obtained a banding pattern that was clearly a mixture and--

8 THE COURT:

How do you know it is clearly a mixture?

9 DR. COTTON:

The best indication from the banding pattern that it is a mixture is that the intensities of the bands in the pattern are different and there are more than eight bands in the cocktail. And in the individual probes there is at least one probe where you see three, so the total number of bands and the differing intensities of the bands confirms that in fact you have more than two people there.

10 MR. CLARKE:

With the Court's--

11 DR. COTTON:

I mean, sorry, more than one person there.

12 MR. CLARKE:

Your Honor, with the Court's permission could we illustrate that by use of the overhead projector?

13 THE COURT:

Yes. I would like to see the autorad.

14 MR. CLARKE:

Dr. Cotton, do you have the original autorad that deals with item 78?

15 DR. COTTON:

Yes.

16 (Brief pause.)
17 MR. CLARKE:

I believe that would have been my next exhibit anyway. Shall we just go ahead and mark that as the People's next in order?

18 THE COURT:

Might as well.

19 MR. CLARKE:

257, I believe.

20 THE COURT:

All right. People's 257, but remark it in front of the jury so that they are aware of it.

21 MR. CLARKE:

Yes.

22 (Peo's 257 for id = autorad)
23 MR. CLARKE:

In fact, I think we may have discussed this yesterday in terms of marking the exhibits, with respect to this particular autorad there is what the witness has just described as a "cocktail," and then there are associated autorads that basically look at the individual loci one at a time, so would the Court like that, for instance, marked 257 a through whatever? I think that might be easier.

24 THE COURT:

All right. If it is associated to the same test, I would assume that would be the most logical way to do it.

25 MR. CLARKE:

It is.

26 THE COURT:

All right.

27 MR. CLARKE:

All right. Dr. Cotton, with regard to this particular test, that involved item no. 78?

28 DR. COTTON:

That's right.

29 MR. CLARKE:

Did it involve any other test samples, that is, evidence samples in this case, other than known samples?

30 DR. COTTON:

Yes. There are two other evidence samples displayed on this film.

31 MR. CLARKE:

What items are those?

32 DR. COTTON:

They are item 52 and item no. 12.

33 MR. CLARKE:

All right. How many autorads total are there in this one particular RFLP test?

34 DR. COTTON:

Seven.

35 MR. CLARKE:

With respect to those autorads, would it be appropriate to begin with what has been referred to as the cocktail autorad?

36 DR. COTTON:

For this purpose I would say yes.

37 MR. CLARKE:

Okay. Then your Honor, if we could mark the cocktail as a.

38 THE COURT:

257-A.

39 (Peo's 257-A for id = autorad cocktail)
40 MR. CLARKE:

And then with respect to the remaining autorads, do they then represent individual loci or individual genetic markers typed one at a time?

41 DR. COTTON:

Yes.

42 MR. CLARKE:

Are there names for each of those markers? Perhaps we can--would the Court like the witness to describe what marker will be b and which marker c and so forth at this point?

43 THE COURT:

You need to show me why this comes in.

44 MR. CLARKE:

All right.

45 THE COURT:

So--

46 MR. CLARKE:

Would it be appropriate to mark the first individual genetic marker test, ms1, as the letter b?

47 DR. COTTON:

Yes.

48 MR. CLARKE:

Is ms1 simply the description of that particular marker?

49 DR. COTTON:

Yes.

50 (Peo's 257-B for id = autorad)
51 MR. CLARKE:

Would it be appropriate to mark as next in order that autorad that deals with the probe ms-31?

52 DR. COTTON:

Yes, but there are two of them and you might want to distinguish--distinguish them by their development date.

53 MR. CLARKE:

Okay. As far as c then, what date should we attach to that?

54 DR. COTTON:

10/11/94.

55 (Peo's 257-C for id = autorad)
56 MR. CLARKE:

And is that date actually on that particular autorad?

57 DR. COTTON:

Yes.

58 MR. CLARKE:

All right. And with respect to the second autorad dealing with this genetic ms-31, what date is it?

59 DR. COTTON:

11/1/94.

60 THE COURT:

All right. That will be d.

61 (Peo's 257-D for id = autorad)
62 MR. CLARKE:

With regard to e, would it be appropriate that that be the particular genetic marker that is the autorad resulting from the test of the genetic marker ms-43?

63 DR. COTTON:

Yes.

(Peo's 257-E for id = autorad).

64 MR. CLARKE:

And that must leave us one genetic marker. Is that g-3?

65 DR. COTTON:

We have two left, g-3 and ynh-24.

66 MR. CLARKE:

So f would be g-3.

67 (Peo's 257-F for id = autorad)
68 DR. COTTON:

Yes.

69 MR. CLARKE:

And g would be ynh-24?

70 DR. COTTON:

Yes.

71 (Peo's 257-G for id = autorad)
72 MR. CLARKE:

Are these letters and numbers simply designations for these different genetic markers?

73 DR. COTTON:

Yes.

74 MR. CLARKE:

All right. Then with the Court's permission what I'm going to ask the witness to do is, first of all, to look at these autorads in the order that they have been marked by projecting them on the elmo machine and then having the Court--I'm sorry, having the witness describe item 78 and its results.

75 THE COURT:

All right.

76 THE COURT:

Counsel, for the purposes of this hearing, what I'm interested in is how do we determine that it is a mixture and then my next question is once I come to the conclusion that there is a scientific basis for determining that there is a mixture, the next thing I'm interested in is why shouldn't I require a statistical analysis or statistical significance factor attached to that conclusion that the party--relevant parties aren't excluded based upon the comments of the NRC at page 59?

77 MR. CLARKE:

I understand.

78 MR. NEUFELD:

Your Honor, just to save time, we will stipulate that it is a mixture so you can get right on to the second issue if you want.

79 THE COURT:

I would like to see it.

80 MR. NEUFELD:

Okay.

81 MR. CLARKE:

All right. Dr. Cotton, could you start with the cocktail then, exhibit 257-A, I believe.

82 (Discussion held off the record between the Deputy District Attorneys.)
83 THE COURT:

Mr. Clarke.

84 MR. CLARKE:

Yes. Thank you, your Honor.

85 MR. CLARKE:

Dr. Cotton, can you now see this particular autorad 257-A, the cocktail?

86 DR. COTTON:

Yes, but it would be easier if I could come down there.

87 MR. CLARKE:

All right. Then with the Court's permission then could the witness come down so that she can view the projector screen and if necessary use the point maker?

88 MR. CLARKE:

Now, Dr. Cotton, without getting into detail about exactly what is on this autorad in terms of items other than 78 and the known samples, is this the particular autorad that would have been the first one developed in your examination using RFLP typing of item 78?

89 DR. COTTON:

Yes, it was.

90 MR. CLARKE:

Now, as far as the--as the results that are shown there, do they demonstrate the existence of a mixture?

91 DR. COTTON:

For item 78 they do.

92 MR. CLARKE:

How do you know that?

93 DR. COTTON:

If you count up the number of bands, if I remember correctly in this cocktail there are eleven. The cocktail is a group of four probes, so if you expect to see two bands maximum with each of four--with each probe, then for a single person with a group of four you would expect to see eight.

94 THE COURT:

Here we have eleven?

95 DR. COTTON:

And here we have eleven.

96 THE COURT:

And they appear to be of differing intensities?

97 DR. COTTON:

Yes. You can see that the lower three bands are much different in intensity than the upper bands--than the band above them and that is the second clear indication that you have a mixture there.

98 MR. CLARKE:

Now, with regard to this initial autoradiograph, and you have described how you are able to determine a mixture, were you able to make any comparisons with known individuals who are also shown on this autorad?

99 DR. COTTON:

There were--essentially you are making comparisons with all the known individuals on the autorad and two of the known individuals on the autorad are consistent with being contributors to item 78.

100 MR. CLARKE:

Who are those two individuals?

101 DR. COTTON:

Nicole Brown and Ronald Goldman.

102 MR. CLARKE:

Now, with respect to these--and you have identified three lower bands as being less in intensity than the remaining bands?

103 DR. COTTON:

Yes.

104 MR. CLARKE:

Are those, based on this initial autorad, and I'm referring to the three bands, the three less intense bands, are they attributable to one person or the other?

105 DR. COTTON:

Yes, they are attributable to or consistent with Mr. Goldman.

106 MR. CLARKE:

Are they consistent or inconsistent, that is, the three bands again, with Nicole Brown?

107 DR. COTTON:

They are inconsistent with Nicole Brown.

108 MR. CLARKE:

Based on this first test or first typing process, using this RFLP method, what conclusions were you then able to reach?

109 DR. COTTON:

For that sample, the conclusion would be that you do have two people there and the possible contributors from the known individuals that we have would be the major amount of DNA coming from or consistent with Nicole Brown, and the minor amount of DNA consistent with some of the bands in Mr. Goldman's pattern. There are not all of his bands there in this cocktail; there are only three.

110 MR. CLARKE:

Is this feature of difference in intensity something that you have experienced in the past in your case work?

111 DR. COTTON:

Yes. It is not at all unusual to see this kind of situation.

112 MR. CLARKE:

Now, do you in fact go further and look at these genetic markers individually?

113 DR. COTTON:

Yes.

114 MR. CLARKE:

All right. First of all, while the cocktail autorad, 257-A is on the projector, are there any further features about this autorad that are significant as far as determining the existence of this mixture and who may or may not have contributed to it?

115 DR. COTTON:

No, I think we've covered them.

116 MR. CLARKE:

All right. Then your Honor, I would like to use 257-B, if I could.

117 THE COURT:

All right. Mr. Clark, at this point I'm persuaded that there is a scientific basis for determining the mixtures here and from what I have learned so far there is a basis to determine that there is an ability to differentiate contributors.

118 MR. CLARKE:

All right.

119 THE COURT:

All right. So let's cut to the chase.

120 MR. CLARKE:

Okay. Actually, perhaps I can do it in just a very short form by asking the witness.

121 MR. CLARKE:

With respect to the remaining autorads that deal with these genetic markers individually, what information, that is what further information, if any, did they provide you in interpreting the existence of this mixture and who may or may not have been a contributor to it?

122 DR. COTTON:

In using the individual films, there is a small additional amount of information. One is on the ms-1 film there are four bands seen. Two are consistent with Nicole Brown and two are consistent with Mr. Goldman, and one of those bands that is seen on that film is not visible on this cocktail. That brings the total number of bands consistent with Mr. Goldman to four and that is the total number of bands through all the testing on 78 that were consistent with Mr. Goldman. There is--I think if I remember correctly, one other piece of information on one of the other probes where you can--you see again one of the three bands that you saw initially and that may be the g-3 probe, although I would have to check to be sure, so you can identify one of the three bands from the cocktail as coming from a specific probe, one of them coming from ms1, one from another one, I think it is g-3. That leaves you a third band on that cocktail that you can't identify which probe it came from and it adds the ms1 individual film, adds a fourth band, giving you a partial pattern of a second person.

123 MR. CLARKE:

All right. Perhaps you could retake the witness stand, Dr. Cotton.

124 (Witness complies.)
125 THE COURT:

Mr. Clarke, let me interrupt you. Mr. Shuman, what article are you reading right now?

126 MR. SHUMAN:

An article about DNA.

127 THE COURT:

All right. I seem to see a picture of the Defendant as you turned it over; is that correct?

128 MR. SHUMAN:

Yes, an article--

129 THE COURT:

All right. While the jury is here, don't do that.

130 MR. SHUMAN:

I will make sure I put it away.

131 THE COURT:

Thank you. Mr. Clarke.

132 MR. CLARKE:

All right. Dr. Cotton, with respect to this mixture as you have described it, you ultimately rendered conclusions about item no. 78 that you placed in your report; is that right?

133 DR. COTTON:

That's right.

134 MR. CLARKE:

What conclusions were reported?

135 DR. COTTON:

We reported that the DNA banding pattern--that the DNA banding pattern from item 78 consisted of two separate patterns. One matches Nicole Brown and there are four bands remaining. Those four bands match four of Mr. Goldman's pattern. And that Mr. Goldman could not be included or definitively included or definitively excluded as the donor of those additional four bands.

136 MR. CLARKE:

With respect to the match between eight of the bands on item 78 and Nicole Brown, did you report a frequency to describe approximately how common or how rare those characteristics shared by item 78, that is, those eight bands and Miss Brown were?

137 DR. COTTON:

Yes, we did.

138 MR. CLARKE:

Did you also report an approximation of the frequencies of the characteristics shared by the additional four bands with Mr. Goldman?

139 DR. COTTON:

No, we did not.

140 MR. CLARKE:

Why not?

141 DR. COTTON:

Because we only had four bands and clearly do not have a complete banding pattern, then the result is basically inconclusive with regard to Mr. Goldman, and we get that based on our opinion that the result was inconclusive. An additional frequency for those bands would not be necessary--we wouldn't normally do that.

142 MR. CLARKE:

Would it be, in your opinion, appropriate to report frequencies for those four additional bands that could have come from Mr. Goldman?

143 DR. COTTON:

There is nothing wrong with doing it. It--it, however, in my opinion, regardless of whether or not you attach a frequency to those four bands, it is still an inconclusive result and therefore attaching that frequency seems somewhat non-helpful.

144 THE COURT:

What frequency calculation did you make for Nicole Brown Simpson?

145 DR. COTTON:

We made a usual frequency calculation for all of the bands that are consistent with her using the frequencies for each band for each probe in the usual multiplication manner.

146 THE COURT:

All right.

147 (Discussion held off the record between the Deputy District Attorneys.)
148 MR. CLARKE:

The Court addressed and you probably heard the Court address the NRC report and calculating frequency data?

149 DR. COTTON:

Yes.

150 MR. CLARKE:

You have--well, first of all, you are familiar with the NRC report?

151 DR. COTTON:

Yes.

152 MR. CLARKE:

And have you read it previously?

153 DR. COTTON:

I have read it many times.

154 MR. CLARKE:

With regard to the NRC report and its discussion of population frequency data, what does it say about calculating frequencies for a situation like Mr. Goldman's four-banded pattern?

155 DR. COTTON:

Mr. Clarke, I didn't read that overnight, so I can't tell you exactly what it says.

156 MR. CLARKE:

Okay. With respect to this type of reporting, in other words, should a frequency in your view be reported for this material? You have described how you didn't do that. You have described also the fact that it can be done. Let's shift your attention to PCR testing. First of all, was PCR typing conducted on material from this same stain?

157 DR. COTTON:

Yes.

158 MR. CLARKE:

With what type of results? Without getting into the actual numbers for each genetic marker, can you tell us what those results revealed?

159 DR. COTTON:

There is clearly a mixture based on the PCR results also.

160 MR. CLARKE:

And how do you reach that conclusion?

161 DR. COTTON:

Umm, if I am remembering correctly, for at least one of the markers there are three alleles and again get more than two, there you have a strong indication you have a second person.

162 (Discussion held off the record between the Deputy District Attorneys.)
163 THE COURT:

Or more than one?

164 DR. COTTON:

Yes, or more than one, sure.

165 THE COURT:

All right.

166 MR. CLARKE:

With regard to those then, in that mixture were you able to determine whether or not individuals in this case, that is the known samples, any of them could be excluded or included?

167 DR. COTTON:

Yes, we were.

168 MR. CLARKE:

With what results as to this particular item and based on PCR typing?

169 DR. COTTON:

The results are basically the same as the RFLP, that Nicole Brown and Mr. Goldman can be included; Mr. Simpson is excluded.

KEY QUOTE
170 MR. CLARKE:

As far as these individuals and their ability to be included, what about assigning population frequency estimates to that? How do you feel about that?

171 DR. COTTON:

We didn't assign any population frequency estimates to that. The signals on the dot-blot are not sufficiently differentiated that you can say these two alleles must be from the major contributor and these--and this other one or two from the minor contributor. You can't really tell this apart on the PCR result, so we didn't attach any frequency to the result at all.

172 MR. CLARKE:

So there was a different situation than the RFLP results where there was clearly a difference in intensity?

173 DR. COTTON:

That's right.

174 MR. CLARKE:

May I have just a moment, your Honor?

175 (Discussion held off the record between the Deputy District Attorneys.)
176 MR. CLARKE:

As far as these results, and let's take them in total now, the RFLP results as well as the PCR-based results, do they provide you any additional information about whether or not it would be appropriate to basically sum up frequencies to describe the significance of these mixtures or these alleles contained in these mixtures?

177 DR. COTTON:

Actually, it is a little easier, I think to think about them separately as opposed to together.

178 MR. CLARKE:

Okay.

179 DR. COTTON:

The PCR mixture, the signals indicate there is a mixture, but it is not--you can't differentiate one contributor from the other. In that case it would not be inappropriate to basically take--do a calculation that says what's the sum of every possible contributor to this mixture. On the RFLP results, however, the signals are so well differentiated and that I think it would be very much understating the strength of the data to do that type of calculation for the RFLP result.

180 (Discussion held off the record between the Deputy District Attorneys.)
181 MR. CLARKE:

Would it be understating it not to provide any frequencies to describe these mixtures or this mixture?

182 DR. COTTON:

I don't see any reason not to provide a frequency for the bands that are consistent with Nicole Brown, that they are so much more intense than the four additional bands. I don't see that calculating a frequency for those four additional bands adds a lot. That is just my opinion.

183 MR. CLARKE:

All right.

184 (Discussion held off the record between the Deputy District Attorneys.)
185 MR. CLARKE:

All right. Thank you.

Temperature

procedural

Key Quotes (4)

Dr. Robin Cotton
The results are basically the same as the RFLP, that Nicole Brown and Mr. Goldman can be included; Mr. Simpson is excluded.
The central DNA conclusion about item 78 — Simpson's DNA was not on Goldman's shoe.
Dr. Robin Cotton
Here we have eleven. You can see that the lower three bands are much different in intensity than the upper bands — that is the second clear indication that you have a mixture there.
Technical explanation to Judge Ito of how a mixture is identified from the autorad, establishing the scientific basis.
Dr. Robin Cotton
Regardless of whether or not you attach a frequency to those four bands, it is still an inconclusive result and therefore attaching that frequency seems somewhat non-helpful.
Cotton's reasoning for not reporting population frequencies for Goldman's partial four-band pattern — the result remains inconclusive either way.
Dr. Robin Cotton
I think it would be very much understating the strength of the data to do that type of calculation for the RFLP result.
Cotton argues the RFLP data is strong enough that a blended mixture frequency calculation would actually diminish its evidentiary weight.

Evidence (10)

People's 257-A
Cocktail autorad from RFLP testing of item 78 showing 11 bands and mixture of two contributors
introduced, displayed on projector, analyzed
People's 257-B
Autorad for genetic marker ms-1
introduced, referenced
People's 257-C
Autorad for genetic marker ms-31, developed 10/11/94
introduced
People's 257-D
Autorad for genetic marker ms-31, developed 11/1/94
introduced
People's 257-E
Autorad for genetic marker ms-43
introduced
People's 257-F
Autorad for genetic marker g-3
introduced
+ 4 more

Notable Exchanges (3)

Lance A. ItoDr. Robin Cotton
Judge Ito actively engaged in the science, asking Cotton to explain how she knew it was 'clearly a mixture' and then confirming 'Here we have eleven?' as Cotton walked through the autorad. Ito cut the examination short once he was satisfied, saying 'let's cut to the chase.'
inquisitive, efficient
Peter NeufeldLance A. Ito
Neufeld offered to stipulate that item 78 is a mixture to save time; Ito declined, saying he wanted to see the autorads himself.
strategic
Lance A. ItoMr. Shuman
Mid-examination, Ito noticed juror Shuman reading an article about DNA that had a photo of the defendant on the back. Ito instructed him not to do that while the jury is present; Shuman agreed to put it away.
corrective

Light Moments (1)

Lance A. Ito
Judge Ito spotted juror Shuman reading a DNA article mid-testimony and caught him turning it over to reveal a photo of OJ Simpson — a quietly awkward moment that Ito handled with dry directness.

Witness Demeanor

(Brief pause.) — while original autorad was retrieved
(Witness complies.) — Cotton returned to witness stand when instructed
Cotton corrected herself mid-answer: 'more than two people there. I mean, sorry, more than one person there.'

Objections

None recorded
Proceeding 5990 • 185 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 10, 1995 📄 Direct examination of Dr. Robi
MAY 10, 1995 KRT DvH TD